GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » COGS-to-Revenue

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) COGS-to-Revenue : 0.72 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL COGS-to-Revenue?

JSP Pharmaceutical Manufacturing (Thailand) PCL's Cost of Goods Sold for the three months ended in Mar. 2024 was ฿112.39 Mil. Its Revenue for the three months ended in Mar. 2024 was ฿155.66 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL's COGS to Revenue for the three months ended in Mar. 2024 was 0.72.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross Margin % for the three months ended in Mar. 2024 was 27.80%.

JSP Pharmaceutical Manufacturing (Thailand) PCL COGS-to-Revenue Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL COGS-to-Revenue Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
0.69 0.68 0.66 0.68 0.75

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.84 0.76 0.71 0.72

JSP Pharmaceutical Manufacturing (Thailand) PCL COGS-to-Revenue Calculation

JSP Pharmaceutical Manufacturing (Thailand) PCL's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=431.103 / 575.578
=0.75

JSP Pharmaceutical Manufacturing (Thailand) PCL's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=112.394 / 155.661
=0.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JSP Pharmaceutical Manufacturing (Thailand) PCL  (BKK:JSP-F) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 112.394 / 155.661
=27.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

JSP Pharmaceutical Manufacturing (Thailand) PCL COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) » Definitions » COGS-to-Revenue
Comparable Companies
BKK:DOD BKK:SSF BKK:NV BKK:SFP BKK:JDF BKK:LEE BKK:BIS BKK:TC BKK:SST BKK:CFRESH XSWX:NESN SHSE:603288 KHC GIS XPAR:BN SHSE:600887 SZSE:300999 HRL MKC K
Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
Website
https://www.jsppharma.com
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-F) Headlines

No Headlines